A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback